Urinary incontinence, the inability to defer or prevent the passage of urine, is a life-altering condition that affects an estimated 17 million adults in the United States (85% of whom are women) , 15 million adults in Europe, and 15 million in the rest of the world. At least one in four American women age 30 to 59 years has experienced urinary incontinence and at least 50% of elderly individuals living at home or in long-term care facilities suffer from this disorder. Urinary incontinence remains the most common reason for institutionalization of elderly Americans. While the disorder is not life-threatening, it is life-altering, often significantly. Despite recently changing attitudes and openness, urinary incontinence is still a heavily stigmatized disorder, and patients suffer embarrassment, depression, shame, as well as professional, social, and sexual insecurity and isolation. Incontinence may lead to loss of confidence, job failure, relationship damage, celibacy, depression, and, rarely, suicidal behavior.
This trial is designed for women with SUI who have had a suboptimal response to surgical intervention. The goal is the demonstration of effectiveness of treatment in these women.
This entire non-surgical, outpatient treatment requires approximately 20-30 minutes. Women are discharged home with no incisions, dressings, or catheters immediately following treatment.
Subjects 18 years of age or older will be enrolled into this prospective, randomized, single blind study and will be followed for a period of 36-42 months following treatment Subjects will receive a small cash payment for participation and follow-up.
If you think this is a research study you may be interested in, we invite you to contact our Research Nurses at 616-588-1135 or sign up for more information.